Blog & News
FDA Proposes Exclusion of GLP-1s from the 503B Bulks List: Implications for Outsourcing Facilities
The U.S. Food and Drug Administration (FDA) continues to refine the regulatory framework governing compounded medications, introducing significant implications...
Read more Regulatory Updates
Optimizing Metabolic Protocols: The Synergistic Role of Levocarnitine, L-Arginine, and Active B12
Medical weight management continues to evolve as practitioners seek safe, effective adjunctive therapies to support patients beyond standard diet and exercise r...
Read more Clinical & Technical Insights
Overcoming Formulation Challenges in Sterile Peptide Injectables and Complex Therapeutics
Peptide therapeutics and complex coenzymes represent one of the fastest-growing sectors in modern medicine. By bridging the gap between small-molecule drugs and...
Read more Case Studies & White Papers